Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis Growth
暂无分享,去创建一个
Gail H. Cassell | J. V. Falvo | V. Hornung | V. Haridas | Thomas S. Ebert | Veit Hornung | James V. Falvo | Anne E. Goldfeld | G. Cassell | A. Goldfeld | Aya Nambu | Shahin Ranjbar | Viraga Haridas | Luke D. Jasenosky | Supriya Sadhukhan | A. Nambu | S. Ranjbar | Thomas Ebert | Supriya Sadhukhan | J. Falvo | Aya Nambu
[1] Bin Wu,et al. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition , 2011, Proceedings of the National Academy of Sciences.
[2] Yong Cheng,et al. Mycobacterium tuberculosis–induced IFN-β production requires cytosolic DNA and RNA sensing pathways , 2018, The Journal of experimental medicine.
[3] E. Rubin,et al. HIV-1 Replication Is Differentially Regulated by Distinct Clinical Strains of Mycobacterium tuberculosis , 2009, PloS one.
[4] H. Einolf,et al. Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches , 2018, Drug Metabolism and Disposition.
[5] J. V. Falvo,et al. A Role for IFITM Proteins in Restriction of Mycobacterium tuberculosis Infection , 2015, Cell reports.
[6] Jeff S. Schorey,et al. Extracellular vesicles deliver Mycobacterium RNA to promote host immunity and bacterial killing , 2019, EMBO reports.
[7] B. Pantenburg,et al. Treatment of cryptosporidiosis , 2009, Expert review of anti-infective therapy.
[8] C. Rice,et al. ATP-dependent effector-like functions of RIG-I-like receptors. , 2015, Molecular cell.
[9] William E. Ortyn,et al. Cellular image analysis and imaging by flow cytometry. , 2007, Clinics in laboratory medicine.
[10] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is an Innate Immune DNA Sensor for Mycobacterium tuberculosis. , 2015, Cell host & microbe.
[11] T. Clark,et al. Primary macrophages and J774 cells respond differently to infection with Mycobacterium tuberculosis , 2017, Scientific Reports.
[12] O. Elroy-Stein,et al. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.
[13] E. Barros,et al. Renal tuberculosis in the modern era. , 2013, The American journal of tropical medicine and hygiene.
[14] J. Parrillo,et al. JAK kinases are required for the bacterial RNA and poly I:C induced tyrosine phosphorylation of PKR. , 2013, International journal of clinical and experimental medicine.
[15] Q. Wen,et al. Different Signaling Pathways Define Different Interferon-Stimulated Gene Expression during Mycobacteria Infection in Macrophages , 2019, International journal of molecular sciences.
[16] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[17] Michael B. Brenner,et al. Regulation of Tumor Necrosis Factor Alpha Gene Expression by Mycobacteria Involves the Assembly of a Unique Enhanceosome Dependent on the Coactivator Proteins CBP/p300 , 2003, Molecular and Cellular Biology.
[18] P. Hipskind,et al. In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis , 2017, ACS omega.
[19] C. Nathan,et al. Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis , 2013, Antimicrobial Agents and Chemotherapy.
[20] M. Curran,et al. Nitazoxanide , 2012, Drugs.
[21] J. V. Falvo,et al. Arc of a vicious circle: pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat. , 2011, American journal of respiratory cell and molecular biology.
[22] V. Hornung,et al. Cytosolic RNA:DNA hybrids activate the cGAS–STING axis , 2014, The EMBO journal.
[23] Stanley N Cohen,et al. Improved Control of Tuberculosis and Activation of Macrophages in Mice Lacking Protein Kinase R , 2012, PloS one.
[24] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[25] Wenting Zhu,et al. An autoinhibitory mechanism modulates MAVS activity in antiviral innate immune response , 2015, Nature Communications.
[26] L. D. de Carvalho,et al. Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis. , 2011, ACS medicinal chemistry letters.
[27] R. Lins,et al. Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. , 1996, International journal of clinical pharmacology and therapeutics.
[28] J. Puglisi,et al. The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation. , 2009, Gastroenterology.
[29] Jonathan L. Schmid-Burgk,et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3 , 2017, Cell.
[30] Ho-Yeon Song,et al. Lack of Activity of Orally Administered Clofazimine against Intracellular Mycobacterium tuberculosis in Whole-Blood Culture , 2004, Antimicrobial Agents and Chemotherapy.
[31] J. Cui,et al. Mechanisms and pathways of innate immune activation and regulation in health and cancer , 2014, Human vaccines & immunotherapeutics.
[32] M. Berg,et al. The multiple faces of proteinkinase R in antiviral defense , 2013, Virulence.
[33] L. D. de Carvalho,et al. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance. , 2009, Journal of medicinal chemistry.
[34] A. Goldfeld,et al. Treatment of drug-resistant tuberculosis among people living with HIV , 2018, Current opinion in HIV and AIDS.
[35] T. Walz,et al. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. , 2013, Molecular cell.
[36] Zhijian J. Chen,et al. MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response , 2011, Cell.
[37] Karen K. Y. Lam,et al. Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosis , 2012, PLoS pathogens.
[38] Cheng-Zhong Zhang,et al. Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation , 2018, Cell.
[39] M. Cooper,et al. Synthesis and pre-clinical studies of new amino-acid ester thiazolide prodrugs , 2016, European Journal of Medicinal Chemistry.
[40] J. Rossignol. Nitazoxanide: A first-in-class broad-spectrum antiviral agent , 2014, Antiviral Research.
[41] A. Pichlmair,et al. Discrimination of Self and Non-Self Ribonucleic Acids. , 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[42] S. Akira,et al. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. , 2014, Cold Spring Harbor perspectives in biology.
[43] Natasha S. Barteneva,et al. Imaging flow cytometry analysis of intracellular pathogens. , 2017, Methods.
[44] V. Hornung,et al. cGAS Senses Human Cytomegalovirus and Induces Type I Interferon Responses in Human Monocyte-Derived Cells , 2016, PLoS pathogens.
[45] D. Hockenbery,et al. Inhibition of vaccinia virus replication by nitazoxanide. , 2018, Virology.
[46] N. Grishin,et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. , 2012, Immunity.
[47] M. Katze,et al. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system , 1991, Molecular and cellular biology.
[48] P. Bevilacqua,et al. Mechanistic Analysis of Activation of the Innate Immune Sensor PKR by Bacterial RNA. , 2015, Journal of molecular biology.
[49] A. Goldfeld,et al. Regulation of Mycobacterium tuberculosis-Dependent HIV-1 Transcription Reveals a New Role for NFAT5 in the Toll-Like Receptor Pathway , 2012, PLoS pathogens.
[50] A. Pichlmair,et al. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.
[51] S. Vogel,et al. Space and time: New considerations about the relationship between Toll-like receptors (TLRs) and type I interferons (IFNs). , 2015, Cytokine.
[52] Jinwei Zhang,et al. The search for a PKR code—differential regulation of protein kinase R activity by diverse RNA and protein regulators , 2019, RNA.
[53] Osamu Takeuchi,et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.
[54] R. Vance,et al. Identification of Host Cytosolic Sensors and Bacterial Factors Regulating the Type I Interferon Response to Legionella pneumophila , 2009, PLoS pathogens.
[55] P. Bevilacqua,et al. Discriminating Self and Non-Self by RNA: Roles for RNA Structure, Misfolding, and Modification in Regulating the Innate Immune Sensor PKR. , 2016, Accounts of chemical research.
[56] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[57] Y. Modis,et al. MDA5 cooperatively forms dimers and ATP‐sensitive filaments upon binding double‐stranded RNA , 2012, The EMBO journal.
[58] S. Kaufmann,et al. Inflammation in tuberculosis: interactions, imbalances and interventions. , 2013, Current opinion in immunology.
[59] P. Pierre,et al. Integration of PKR‐dependent translation inhibition with innate immunity is required for a coordinated anti‐viral response , 2015, FEBS letters.
[60] C. Samuel,et al. The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. , 2003, Virology.
[61] W. Bishai,et al. A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis , 2015, Nature Medicine.
[62] D. Rosillon,et al. Nitazoxanide pharmacokinetics and tolerability in man during 7 days dosing with 0.5 g and 1 g b.i.d. , 2002, International journal of clinical pharmacology and therapeutics.
[63] E. Kurbatova,et al. Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters , 2017, The Journal of antimicrobial chemotherapy.
[64] Z. Zhai,et al. VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .
[65] D. Portnoy,et al. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. , 2012, Cell host & microbe.
[66] J. Hiscott,et al. Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways. , 2017, Trends in immunology.
[67] Zhijian J. Chen,et al. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I , 2014, Nature.
[68] S. Hur,et al. How RIG-I like receptors activate MAVS. , 2015, Current opinion in virology.
[69] Jonathan L. Schmid-Burgk,et al. Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1. , 2015, Cell host & microbe.
[70] M. Esteban,et al. Interferon inhibits Viral Protein Synthesis in L Cells infected with Vaccinia Virus , 1972, Nature.
[71] Y. Lau,et al. A Role for Double-Stranded RNA-Activated Protein Kinase PKR in Mycobacterium-Induced Cytokine Expression1 , 2005, The Journal of Immunology.
[72] S. Akira,et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5 , 2008, The Journal of experimental medicine.
[73] T. Walz,et al. Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5 , 2013, Cell.
[74] Jonathan L. Schmid-Burgk,et al. OutKnocker: a web tool for rapid and simple genotyping of designer nuclease edited cell lines , 2014, Genome research.
[75] H. Virgin,et al. The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy. , 2015, Cell host & microbe.
[76] P. Hunter,et al. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. , 2007, British journal of clinical pharmacology.
[77] M. Hayakari,et al. Critical Role of IRF-3 in the Direct Regulation of dsRNA-Induced Retinoic Acid-Inducible Gene-I (RIG-I) Expression , 2016, PloS one.
[78] A. Sher,et al. Type I interferons in tuberculosis: Foe and occasionally friend , 2018, The Journal of experimental medicine.
[79] D. Siegler,et al. Pulmonary tuberculosis , 1951 .
[80] V. Hornung,et al. cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING , 2013, Nature.
[81] C. Samuel,et al. Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR , 1993, Journal of virology.
[82] P. Escalante. Tuberculosis , 1904, Annals of Internal Medicine.
[83] G. Hartmann,et al. RIG‐I detects infection with live Listeria by sensing secreted bacterial nucleic acids , 2012, The EMBO journal.
[84] Olaf Wolkenhauer,et al. Diagnostic Potential of Imaging Flow Cytometry. , 2018, Trends in biotechnology.
[85] Jonathan L. Schmid-Burgk,et al. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. , 2014, Immunity.
[86] C. Nathan,et al. Evidence for dispensability of protein kinase R in host control of tuberculosis , 2018, European journal of immunology.
[87] Y. Modis,et al. Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5 , 2014, Front. Immunol..
[88] C. Prinz,et al. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. , 2009, Gastroenterology.
[89] P. Penczek,et al. Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. , 2014, Molecular cell.
[90] W. Boom,et al. Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture. , 2016, Tuberculosis.
[91] M. Tatematsu,et al. Extracellular RNA Sensing by Pattern Recognition Receptors , 2018, Journal of Innate Immunity.
[92] John L. Johnson,et al. Whole blood bactericidal activity during treatment of pulmonary tuberculosis. , 2003, The Journal of infectious diseases.
[93] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[94] F. Giannoni,et al. Activities of Drug Combinations against Mycobacterium tuberculosis Grown in Aerobic and Hypoxic Acidic Conditions , 2013, Antimicrobial Agents and Chemotherapy.
[95] T. Butters,et al. Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores. , 2014, Virology.
[96] S. Fortune,et al. Requirement for Invariant Chain in Macrophages for Mycobacterium tuberculosis Replication and CD1d Antigen Presentation , 2011, Infection and Immunity.
[97] S. Bavari,et al. The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus , 2019, iScience.
[98] Anand Kumar,et al. Bacterial RNA induces myocyte cellular dysfunction through the activation of PKR. , 2012, Journal of thoracic disease.
[99] S. Goodbourn,et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[100] K. Rosenblum,et al. PKR: A Kinase to Remember , 2019, Front. Mol. Neurosci..
[101] T. Kawai,et al. Discrimination Between Self and Non-Self-Nucleic Acids by the Innate Immune System , 2018, International Review of Cell and Molecular Biology.
[102] Shizuo Akira,et al. Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1 , 2005, The Journal of Immunology.
[103] A. Hovanessian,et al. Autophosphorylation of the protein kinase dependent on double-stranded RNA. , 1987, The Journal of biological chemistry.
[104] Gunther Hartmann,et al. 5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.
[105] Zhijian J. Chen,et al. Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.
[106] T. Moran,et al. Cytokine-Independent Upregulation of MDA5 in Viral Infection , 2007, Journal of Virology.